Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
Global Rat Model Market Size study, by Model Type (Outbred Rats, Inbred Rats, Knockout/Genetically Modified Rats, Hybrid/Congenic Rats, Conditioned/Surgically Modified Rats, Immunodeficient Rats), by Service (Breeding, Cryopreservation, Quarantine, Rederivation, Model-in-licensing, Genetic Testing, Other Services), by End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs)) and Regional Forecasts 2022-2028
... End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs)) and Regional Forecasts 2022-2028 Global Rat Model Market is valued at approximately USD 16.4 billion in 2021 and is anticipated to grow ... Read More
-
Global Synthetic Stem Cells Market Size study, by Application (Cardiovascular Disease, Neurological Disorders, Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorder), By End-Use (Hospitals And Surgical Centers, Academic Institutes, Research Laboratories, Pharmaceutical And Biotechnology Companies, Others) and Regional Forecasts 2022-2028
... Forecasts 2022-2028 Global Synthetic Stem Cells Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period ... Read More
-
2022 Global Forecast for Amniotic Products (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
2022 Global Forecast for Human Organoids (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Rat Model Market Size By Rat Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application (Research & Development, {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production and Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 - 2028
... Diseases, Neurological Diseases}, Production and Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, ... Read More
-
Global Acellular Therapy Market - Strategies and Applications: Focus on Application, Pipeline, and Competitive Landscape
... of Extracellular Vesicles (EVs) in Regenerative Medicine Acellular Therapy: A Novel Approach for COVID-19 Expert Insights Clinical Trial Analysis: Acellular Therapy Extracellular Vesicles-Based Therapeutics: Regulatory Aspects Competitive Landscape Key Companies Profiled Aegle Therapeutics Corp, ArunA ... Read More
-
2022 Global Forecast for Stem Cell Banking (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
2022 Global Forecast for Stem Cell Manufacturing (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
2022 Global Forecast for Stem Cell Assay (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
2022 Global Forecast for Synthetic Stem Cells (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Global Cell Therapy Market 2022-2028
... may be used as part of a therapy or treatment for a variety of diseases and conditions. Projected to expand at a CAGR of 6.3% from 2022 to 2028, the global cell therapy market will ... Read More
-
Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026
... valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences ... Read More
-
Gene Therapy Market By Vector Type (Viral Vector, Non Viral Vector), By Therapy (In Vivo Therapy, Ex Vivo Therapy), By Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors, Others), By Application (Oncological Disorders, Rare Diseases, Neurological Disorders, Other Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2030
... Disorders, Rare Diseases, Neurological Disorders, Other Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2030 Genes are composed of DNA that contains the necessary information to produce proteins that are vital for the human body to ... Read More
-
Latin America, Middle East & Africa Stem Cell Therapy Market Databank
... CAGR of 2.88% from 2021 to 2029. Allogenic stem cell therapy segment is expected to be the highest contributor to this market, with $6,832.3 Million in 2020, and is anticipated to reach $8,851.5 Million by ... Read More
-
Global Stem Cell Therapy Market Databank
... to 2029. Allogenic stem cell therapy segment is expected to be the highest contributor to this market, with $6,832.3 Million in 2020, and is anticipated to reach $8,851.5 Million by 2029, registering a CAGR of ... Read More
-
Nerve Repair and Regeneration Market By Product (Biomaterials, Neuromodulation Surgery Devices), By Surgery (Direct Neuropathy, Nerve Grafting, Stem Cell Therapy, Neuromodulation Surgery): Global Opportunity Analysis and Industry Forecast, 2020-2030
... or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm-shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The ... Read More
-
CAR T-Cell Therapy Market: Current Analysis and Forecast (2021-2027)
... patient’s blood and are modified in the laboratory for attacking the cancer cells. CAR T-cell therapy is most commonly used to treat certain blood cancers and is being studied for the treatment of other cancer ... Read More
-
Europe Stem Cell Therapy Market Databank
... to 2029. Allogenic stem cell therapy segment is expected to be the highest contributor to this market, with $6,832.3 Million in 2020, and is anticipated to reach $8,851.5 Million by 2029, registering a CAGR of ... Read More
-
Leading Stem Cell Therapy Type Markets Databank
... 2021 to 2029. Allogenic stem cell therapy segment is expected to be the highest contributor to this market, with $6,832.3 Million in 2020, and is anticipated to reach $8,851.5 Million by 2029, registering a CAGR ... Read More
-
Mesenchymal Stem Cells - Advances and Applications, 2022
... adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cells types for a ... Read More
-
2022 Global Humanized Mouse And Rat Model Industry (2028 Outlook)
... Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product ... Read More
-
North America Stem Cell Therapy Market Databank
... 2021 to 2029. Allogenic stem cell therapy segment is expected to be the highest contributor to this market, with $6,832.3 Million in 2020, and is anticipated to reach $8,851.5 Million by 2029, registering a CAGR ... Read More
-
Asia-Pacific Stem Cell Therapy Market Databank
... to 2029. Allogenic stem cell therapy segment is expected to be the highest contributor to this market, with $6,832.3 Million in 2020, and is anticipated to reach $8,851.5 Million by 2029, registering a CAGR of ... Read More
-
Leading Stem Cell Therapy Country Markets Databank
... 2021 to 2029. North America is expected to be the highest contributor to this market, with $3,266.3 Million in 2020, and is anticipated to reach $4,013.4 Million by 2029, registering a CAGR of 2.35%. Asia-Pacific ... Read More
-
Leading Stem Cell Therapy End-Use Markets Databank
... 2021 to 2029. Hospitals segment is expected to be the highest contributor to this market, with $3,483.1 Million in 2020, and is anticipated to reach $4,478.2 Million by 2029, registering a CAGR of 2.87%. Clinics ... Read More
Research Assistance
